Micheal Hebert focuses his practice on counseling clients on strategies for formulating and prosecuting patent portfolios to maximize intellectual property protection in several areas of the life sciences. His practice includes drafting and prosecuting U.S. and international patent applications in microbial genetics, personalized medicine, gene therapy, antibodies, stem cells, pharmaceuticals, and molecular biology. Micheal also has extensive experience conducting due diligence research and analysis for freedom-to-operate investigations, patent validity opinions, patentability opinions, and technology licensing. In conducting due diligence research, Micheal is proficient in searching patent databases, nonpatent literature databases, and nucleic/amino acid sequence alignment databases.Prior to joining Jones Day in 2010, Micheal was a patent agent and scientific advisor at two international law firms. He was also a postdoctoral fellow at Stanford University where he worked with Mark A. Kay, M.D., Ph.D. in the field of human gene therapy and viral vector development. While at Stanford, he was the recipient of the National Hemophilia Foundation Judith Graham Pool Postdoctoral Fellowship and was awarded the Ruth L. Kirschstein National Research Service Award from the National Institutes of Health. While earning his Ph.D. at the University of Texas at Houston Health Science Center, Micheal worked with Robert D. Wells, Ph.D. in the areas of hereditary neurological diseases, DNA structure, and cellular mechanisms of recombination, repair, and replication.